These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34698107)

  • 1. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.
    Pulverer W; Kruusmaa K; Schönthaler S; Huber J; Bitenc M; Bachleitner-Hofmann T; Bhangu JS; Oehler R; Egger G; Weinhäusel A
    Curr Issues Mol Biol; 2021 Oct; 43(3):1419-1435. PubMed ID: 34698107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
    BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy.
    Chen K; Sun J; Zhao H; Jiang R; Zheng J; Li Z; Peng J; Shen H; Zhang K; Zhao J; Zhu S; Wang Y; Yang F; Wang J
    Mol Cancer; 2021 Jan; 20(1):23. PubMed ID: 33514352
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
    Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
    FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Barault L; Amatu A; Siravegna G; Ponzetti A; Moran S; Cassingena A; Mussolin B; Falcomatà C; Binder AM; Cristiano C; Oddo D; Guarrera S; Cancelliere C; Bustreo S; Bencardino K; Maden S; Vanzati A; Zavattari P; Matullo G; Truini M; Grady WM; Racca P; Michels KB; Siena S; Esteller M; Bardelli A; Sartore-Bianchi A; Di Nicolantonio F
    Gut; 2018 Nov; 67(11):1995-2005. PubMed ID: 28982739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
    Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
    Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed and Sensitive DNA Methylation Testing Using Methylation-Sensitive Restriction Enzymes "MSRE-qPCR".
    Beikircher G; Pulverer W; Hofner M; Noehammer C; Weinhaeusel A
    Methods Mol Biol; 2018; 1708():407-424. PubMed ID: 29224156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
    Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
    Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
    Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
    Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
    Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
    Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.